| dc.contributor.author | Chisholm, J | |
| dc.date.accessioned | 2021-08-04T14:33:58Z | |
| dc.date.available | 2022-08-04T14:33:58Z | |
| dc.identifier.citation | European Journal of Cancer | |
| dc.identifier.issn | 0959-8049 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4722 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | European School of Oncology (ESO) | |
| dc.rights.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| dc.title | Role of 18F-FDG-PET/CT in the staging of metastatic rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2021-07-12 | |
| rioxxterms.version | AM | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/under-embargo-all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2021-07-12 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | European Journal of Cancer | |
| pubs.notes | 12 months | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Accepted | |
| pubs.embargo.terms | 12 months | |
| pubs.embargo.date | 2022-08-04T14:33:59Z | |
| icr.researchteam | Sarcoma Clinical Trials in children and young people | |
| icr.researchteam | Sarcoma Clinical Trials in children and young people | en_US |
| dc.contributor.icrauthor | Chisholm, Julia | |
